Zhao Wensi, Qiu Hu, Gong Yi, Han Chen, Ruan Shasha, Wang Chenyu, Chen Jiamei, Ke Shaobo, Shi Wei, Wang Jing, Xu Qiuni, Li Yan, Shi Yuxia, Chen Qian, Chen Yongshun
Department of Clinical Oncology, Renmin Hospital of Wuhan University Wuhan 430060, China.
Am J Cancer Res. 2020 Aug 1;10(8):2282-2292. eCollection 2020.
The ongoing outbreak of the coronavirus disease 2019 (COVID-19) has become an unprecedented threat to public health around the world. The crisis has also brought great challenges to the routine diagnosis and treatment of cancer patients, especially given the urgency and continuity of cancer care. Cancer patients need to be more prudently and individually managed to combat COVID-19. At present, the COVID-19 epidemic in some countries has moved from the outbreak phase to the remission phase. How to preserve high-quality anti-tumor therapy for cancer patients while maintaining strict prevention and control of COVID-19 is a matter of concern. Here, we summarized essential data about COVID-19 and cancer and provided the clinical recommendations for the management of cancer patients during the COVID-19 pandemic based on our practical experience and relevant literatures.
2019年冠状病毒病（COVID-19）的持续爆发已成为全球公共卫生前所未有的威胁。这场危机也给癌症患者的常规诊断和治疗带来了巨大挑战，尤其是考虑到癌症护理的紧迫性和连续性。癌症患者需要更谨慎、个性化地管理以对抗COVID-19。目前，一些国家的COVID-19疫情已从爆发阶段进入缓解阶段。如何在严格防控COVID-19的同时为癌症患者保留高质量的抗肿瘤治疗是一个备受关注的问题。在此，我们总结了关于COVID-19和癌症的重要数据，并根据我们的实践经验和相关文献，为COVID-19大流行期间癌症患者的管理提供临床建议。
